for the record food allergen labelling four years later ...food allergen labelling i n a bid to...

1
News CMAJ AUGUST 26, 2008 179(5) © 2008 Canadian Medical Association or its licensors 415 Four years later, roadblocks to AIDS drugs overcome I n the end, the Commissioner for Patents had to issue a compulsory licence, but at long last, low-cost life-saving AIDS drugs are scheduled to be shipped to Rwanda this fall un- der legislation Canada passed more than 4 years ago. Canada received kudos from around the world when in May 2004 it became the first country to implement a World Trade Organization (WTO) agreement designed to get affordable, life-saving drugs to the developing world in a timely fashion. Next month, Canadian generic drug manufacturer Apotex Inc. expects to ship a supply of a specially manufac- tured, low-cost, triple-combination AIDS drug that will treat 21 000 Rwan- dans for a year, says spokesperson Elie Betito. “It is a victory to see this first use of the legislation,” says Richard El- liott, deputy director of the Canadian HIV/AIDS Legal Network, which was instrumental in lobbying for the new law. “But it will be bittersweet if it turns out to be the only shipment to go out.” To date, Apotex is the only com- pany in the world that has manufac- tured drugs for the developing world as a result of the WTO provision. The legislation, originally the Jean Chrétien Pledge to Africa Act but re- named the Canadian Access to Medi- cines Regime, has been criticized as unnecessarily cumbersome by the legal network and others. The WTO agreement provided for generic drug companies to apply for li- cences to patented drugs in order to manufacture affordable generic ver- sions of drugs for use in developing countries. The compulsory licence was issued in September 2007, after Apotex was unable to obtain voluntary licences from the patent-holders. The compulsory licence authorizes export only of a designated quantity of medicine to a single country; the whole process will have to be repeated for fur- Food allergen labelling I n a bid to increase protection for food allergy sufferers, Health Canada has announced new la- belling requirements for food aller- gens, gluten sources and added sul- phites contained in prepackaged foods. The new requirements will oblige manufacturers to list on their label all: • proteins derived from “almonds, Brazil nuts, cashews, hazelnuts, macadamia nuts, pecans, pine nuts, pistachios or walnuts; peanuts; sesame seeds; wheat, kamut, spelt or triticale; eggs; milk; soybeans; crus- taceans; shellfish; or fish.” gluten sources; in other words, when a food contains a protein produced from barley, oats, rye, triticale or wheat, including kamut or spelt. • sulphites “when either directly added to a food or when the total amount of sulphites present in the food is 10 parts per million or more.” — Wayne Kondro, CMAJ DOI:10.1503/cmaj.081146 ther drug orders from Rwanda or an- other country. Eliott says Canada could easily streamline the process in order to “in- crease access to affordable drugs for tens or hundreds of thousands of people in the developing world. The unan- swered question is whether parliamen- tarians have the political will to take action to improve access to AIDS drugs,” he wrote in the July 2008 issue of the network’s Policy and Law Re- view. The legal network and the Global Treatment Action Group submitted de- tailed proposals for amendments to the federal Government’s 2007 review of the legislation. However, in its Decem- ber 2007 report, the Minister of Indus- try indicated that it would be premature to amend the legislation. Apotex President Jack Kay has said that unless the process is streamlined, his company won't seek to produce an- other needed drug. But Elliott pointed to the need for a pediatric formulation of the combination AIDS drug and said he hoped Apotex might be open to work- ing on it. — Ann Silversides, CMAJ For the record Safer water saves lives W ater-related deaths are rare in Canada, but a new World Health Organization (WHO) report indi- cates a large percentage of deaths in other countries could be prevented by increasing ac- cess to safe drinking water, improving sanita- tion and hygiene, and by better managing wa- ter resources to reduce drownings and the spread of infectious diseases. The report, entiled Safer Water, Better Health, claims 0.2% of deaths in Canada in 2002 were due to drownings. In other countries, however, water supply problems resulted in deaths from diarrhea (1.4 million child deaths), malnutrition (860 000 child deaths) and malaria (500 000 deaths). Developing countries were hit particularly hard. In Burkina Faso, 19.9% of deaths in 2002 were water-related, while the rate was 20.4% for the Demo- cratic Republic of the Congo and 24.1% for Angola. The WHO claims a US$11 billion annual investment to improve water safety and management would save health agencies US$7 billion a year and save individuals US$340 million a year. In addition, it would result in the gain of 320 million work days for adults and 270 million school days for chil- dren. The total payback, the WHO estimates, could reach US$84 billion a year. — Roger Collier, CMAJ iStock photos

Upload: others

Post on 03-Jun-2020

4 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: For the record Food allergen labelling Four years later ...Food allergen labelling I n a bid to increase protection for food allergy sufferers, Health Canada has announced new la-belling

News

CMAJ • AUGUST 26, 2008 • 179(5)© 2008 Canadian Medical Association or its licensors

415

Four years later, roadblocks

to AIDS drugs overcome

In the end, the Commissioner forPatents had to issue a compulsorylicence, but at long last, low-cost

life-saving AIDS drugs are scheduledto be shipped to Rwanda this fall un-der legislation Canada passed morethan 4 years ago.

Canada received kudos from aroundthe world when in May 2004 it becamethe first country to implement a WorldTrade Organization (WTO) agreementdesigned to get affordable, life-savingdrugs to the developing world in atimely fashion.

Next month, Canadian generic drugmanufacturer Apotex Inc. expects toship a supply of a specially manufac-tured, low-cost, triple-combinationAIDS drug that will treat 21 000 Rwan-dans for a year, says spokesperson ElieBetito.

“It is a victory to see this first useof the legislation,” says Richard El-liott, deputy director of the CanadianHIV/AIDS Legal Network, which wasinstrumental in lobbying for the newlaw. “But it will be bittersweet if itturns out to be the only shipment togo out.”

To date, Apotex is the only com-pany in the world that has manufac-tured drugs for the developing world asa result of the WTO provision.

The legislation, originally the JeanChrétien Pledge to Africa Act but re-named the Canadian Access to Medi-cines Regime, has been criticized asunnecessarily cumbersome by the legalnetwork and others.

The WTO agreement provided forgeneric drug companies to apply for li-cences to patented drugs in order tomanufacture affordable generic ver-sions of drugs for use in developingcountries. The compulsory licence wasissued in September 2007, after Apotexwas unable to obtain voluntary licencesfrom the patent-holders.

The compulsory licence authorizesexport only of a designated quantity ofmedicine to a single country; the wholeprocess will have to be repeated for fur-

Food allergen labelling

In a bid to increase protection forfood allergy sufferers, HealthCanada has announced new la-

belling requirements for food aller-gens, gluten sources and added sul-phites contained in prepackaged foods.

The new requirements will obligemanufacturers to list on their label all: • proteins derived from “almonds,

Brazil nuts, cashews, hazelnuts,macadamia nuts, pecans, pine nuts,pistachios or walnuts; peanuts;sesame seeds; wheat, kamut, spelt ortriticale; eggs; milk; soybeans; crus-taceans; shellfish; or fish.”

• gluten sources; in other words, whena food contains a protein producedfrom barley, oats, rye, triticale orwheat, including kamut or spelt.

• sulphites “when either directlyadded to a food or when the totalamount of sulphites present in thefood is 10 parts per million ormore.” — Wayne Kondro, CMAJ

DOI:10.1503/cmaj.081146

ther drug orders from Rwanda or an-other country.

Eliott says Canada could easilystreamline the process in order to “in-crease access to affordable drugs fortens or hundreds of thousands of peoplein the developing world. The unan-swered question is whether parliamen-tarians have the political will to takeaction to improve access to AIDSdrugs,” he wrote in the July 2008 issueof the network’s Policy and Law Re-view. The legal network and the GlobalTreatment Action Group submitted de-tailed proposals for amendments to thefederal Government’s 2007 review ofthe legislation. However, in its Decem-ber 2007 report, the Minister of Indus-try indicated that it would be prematureto amend the legislation.

Apotex President Jack Kay has saidthat unless the process is streamlined,his company won't seek to produce an-other needed drug. But Elliott pointed tothe need for a pediatric formulation ofthe combination AIDS drug and said hehoped Apotex might be open to work-ing on it. — Ann Silversides, CMAJ

For the record

Safer water saves lives

Water-related deaths are rare inCanada, but a new World HealthOrganization (WHO) report indi-

cates a large percentage of deaths in othercountries could be prevented by increasing ac-cess to safe drinking water, improving sanita-tion and hygiene, and by better managing wa-ter resources to reduce drownings and thespread of infectious diseases.

The report, entiled Safer Water, BetterHealth, claims 0.2% of deaths in Canada in2002 were due to drownings. In other countries,however, water supply problems resulted indeaths from diarrhea (1.4 million child deaths), malnutrition (860 000 childdeaths) and malaria (500 000 deaths).

Developing countries were hit particularly hard. In Burkina Faso, 19.9%of deaths in 2002 were water-related, while the rate was 20.4% for the Demo-cratic Republic of the Congo and 24.1% for Angola.

The WHO claims a US$11 billion annual investment to improve watersafety and management would save health agencies US$7 billion a year andsave individuals US$340 million a year. In addition, it would result in thegain of 320 million work days for adults and 270 million school days for chil-dren. The total payback, the WHO estimates, could reach US$84 billion ayear. — Roger Collier, CMAJ

iSto

ck p

ho

tos